Emergent BioSolutions (EBS) Notes Payables (2016 - 2024)
Emergent BioSolutions' Notes Payables was $800,000 in Q3 2024, down 99.8% from $413.6 million a year earlier and down 99.8% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Notes Payables (2016 - 2024) Analysis & Trends
At the end of FY2023, Notes Payables at Emergent BioSolutions came in at $413.7 million, down 56.8% from FY2022.
- Notes Payables shows a five-year compound annual growth rate of 110.1% (FY2018 to FY2023).
- In earlier years, Notes Payables was $957.3 million in FY2022, $31.6 million in FY2021 (-6.5%), $33.8 million in FY2020 (+162.0%) and $12.9 million in FY2019 (+27.7%).
- The Q3 2024 figure marks the lowest quarterly Notes Payables in data going back to Q3 2016.
- Compared with a year earlier, Notes Payables has declined for four straight quarters, with an average decline of 54.3% over the last four quarters.
- The best year-over-year quarter for Notes Payables over five years was Q4 2020 (growth of 162.0%); the worst was Q3 2024 (a decline of 99.8%).
- Per Business Quant data, EBS's Notes Payables in the three quarters before Q3 2024 was $415.2 million (Q2 2024), $459.2 million (Q1 2024) and $413.7 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 415.20 Mn |
| Mar 31, 2024 | 459.20 Mn |
| Dec 31, 2023 | 413.70 Mn |
| Sep 30, 2023 | 413.60 Mn |
| Jun 30, 2023 | 455.20 Mn |
| Mar 31, 2023 | 950.70 Mn |
| Dec 31, 2022 | 957.30 Mn |
| Sep 30, 2022 | 21.20 Mn |
| Jun 30, 2022 | 31.60 Mn |
| Mar 31, 2022 | 31.60 Mn |
| Dec 31, 2021 | 31.60 Mn |
| Sep 30, 2021 | 31.60 Mn |
| Jun 30, 2021 | 28.80 Mn |
| Mar 31, 2021 | 26.00 Mn |
| Dec 31, 2020 | 33.80 Mn |
| Sep 30, 2020 | 30.90 Mn |
| Jun 30, 2020 | 29.10 Mn |
| Mar 31, 2020 | 26.30 Mn |
| Dec 31, 2019 | 12.90 Mn |
API Access
Emergent BioSolutions Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();